Keyphrases
1-year Mortality
7%
Acute Coronary Syndrome
9%
Acute Kidney Injury
19%
Acute Myocardial Infarction
41%
Adverse Cardiac Events
8%
All-cause Mortality
14%
Anemia
8%
Carotid Artery Stenosis
9%
Clinical Outcomes
22%
Confidence Interval
15%
Consecutive Patients
13%
Coronary Angiography
17%
Coronary Artery Disease
12%
Drug-eluting Stent
10%
Early Repolarization
7%
Edwards SAPIEN
10%
Effort Intolerance
7%
Erythrocyte Aggregation
9%
Evolut R
8%
Forced Diuresis
8%
Hazard Ratio
15%
Israeli
11%
Left Ventricular Ejection Fraction
11%
Left Ventricular Function
9%
Long QT Syndrome
8%
Long-term Mortality
19%
Long-term Survival
8%
Major Adverse Cardiovascular Events
9%
Medtronic
7%
Myocardial Infarction
16%
Myocardial Infarction Patients
11%
Odds Ratio
8%
Patient Selection
7%
Percutaneous Coronary Intervention
28%
Percutaneous Intervention
9%
Peri-procedural
17%
Post-procedural
9%
Primary Angioplasty
9%
Primary Percutaneous Coronary Intervention
22%
Prognostic Implications
8%
Red Cell Distribution Width
12%
Severe Aortic Stenosis
16%
Single-center Experience
7%
ST-elevation Myocardial Infarction (STEMI)
11%
Stable Angina
8%
Stent
8%
Sudden Death
8%
Transcatheter Aortic Valve Implantation
65%
Transcatheter Aortic Valve Replacement
39%
Vascular Complications
8%
Medicine and Dentistry
Abciximab
5%
Acute Coronary Syndrome
7%
Acute Heart Infarction
35%
Acute Kidney Injury
14%
All Cause Mortality
13%
Anemia
10%
Angiography
8%
Angioplasty
13%
Aortic Stenosis
19%
Aortic Valve
8%
Aortic Valve Prosthesis
13%
Apoplexy
8%
Cardiovascular Disease
9%
Carotid Artery Stenosis
9%
Carotid Atherosclerosis
5%
Computed Tomography Angiography
6%
Congestive Heart Failure
9%
Coronary Angiography
10%
Coronary Artery
8%
Coronary Artery Disease
17%
Coronary Circulation
8%
Diabetes Mellitus
8%
Diseases
8%
Diuresis
7%
Drug-Eluting Stent
11%
Echocardiography
7%
Ejection Fraction
8%
Erythrocyte Aggregation
7%
Hazard Ratio
13%
Heart Left Ventricle Ejection Fraction
10%
Heart Left Ventricle Function
7%
Infarction
5%
Kidney Function
6%
Lymphocyte
7%
Major Adverse Cardiac Event
7%
Mortality Rate
5%
Myocardial Infarction
22%
Neutrophil
7%
Odds Ratio
7%
Pacemaker Implantation
6%
Percutaneous Aortic Valve Replacement
100%
Percutaneous Coronary Intervention
30%
Percutaneous Intervention
8%
Prevalence
10%
Primary Percutaneous Coronary Intervention
21%
Red Blood Cell Distribution Width
7%
Reperfusion Therapy
6%
ST Segment Elevation Myocardial Infarction
7%
Stenting
6%
Thrombus
6%
